Paris - Delayed Quote EUR
ABIONYX Pharma SA (ABNX.PA)
1.2480
-0.0340
(-2.65%)
At close: June 13 at 5:23:41 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 2 | 2 |
| Avg. Estimate | 0 | 0 | -0.28 | -0.36 |
| Low Estimate | 0 | 0 | -0.34 | -0.52 |
| High Estimate | 0 | 0 | -0.23 | -0.19 |
| Year Ago EPS | -- | -- | -0.13 | -0.28 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 2 | 2 |
| Avg. Estimate | -- | -- | 4.81M | 6.66M |
| Low Estimate | -- | -- | 4.6M | 5.22M |
| High Estimate | -- | -- | 5.02M | 8.1M |
| Year Ago Sales | -- | -- | 4.6M | 4.81M |
| Sales Growth (year/est) | -- | -- | 4.55% | 38.47% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | -0.28 | -0.36 |
| 7 Days Ago | 0 | 0 | -0.28 | -0.36 |
| 30 Days Ago | 0 | 0 | -0.22 | -0.19 |
| 60 Days Ago | 0 | 0 | -0.22 | -0.16 |
| 90 Days Ago | 0 | 0 | -0.23 | -0.17 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | 1 | 1 |
| Down Last 30 Days | -- | -- | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ABNX.PA | -- | -- | -118.85% | -24.81% |
| S&P 500 | 13.13% | 2.41% | 7.55% | 14.06% |
Related Tickers
IPH.PA Innate Pharma S.A.
1.6900
-1.40%
ADOC.PA Adocia SA
3.6200
-2.29%
DBV.PA DBV Technologies S.A.
1.5860
-3.65%
GLPG.AS Galapagos NV
25.36
+2.09%
ITOS iTeos Therapeutics, Inc.
10.17
+1.90%
TERN Terns Pharmaceuticals, Inc.
3.8800
-1.27%
ALLO Allogene Therapeutics, Inc.
1.3400
-4.29%
MDGL Madrigal Pharmaceuticals, Inc.
295.57
-0.55%
VKTX Viking Therapeutics, Inc.
26.08
-8.75%